
AstraZeneca's COVID-19 vaccine offers stronger immunity with 45-week gap between doses, company says
Fox News
A longer, 10-month delay in administering second doses of AstraZeneca’s COVID-19 vaccine afforded trial participants stronger immunity, the company announced Monday, aiming to assuage concerns of compromised immunity among populations of countries with short vaccine supply.
Study authors suggested the results can help inform more flexible vaccination schedules. "This should come as reassuring news to countries with lower supplies of the vaccine, who may be concerned about delays in providing second doses to their populations," Andrew Pollard, chief investigator and director of the Oxford Vaccine Group at the University of Oxford, said in a statement. "There is an excellent response to a second dose, even after a 10 month delay from the first."More Related News

NASA begins infrastructure overhaul under Isaacman as Trump pushes ambitious space exploration goals
NASA Administrator Jared Isaacman demolish facilities Alabama Marshall Space Flight Center Saturday as space agency modernizes infrastructure under new leadership.












